Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov;163(2):555-562.
doi: 10.1002/ijgo.14850. Epub 2023 May 14.

Assessment of abnormal placentation in pregnancies conceived with assisted reproductive technology

Affiliations

Assessment of abnormal placentation in pregnancies conceived with assisted reproductive technology

Caroline J Violette et al. Int J Gynaecol Obstet. 2023 Nov.

Abstract

Objective: To examine the association between assisted reproductive technology (ART) and abnormal placentation.

Methods: This is a retrospective cohort study querying the Healthcare Cost and Utilization Project's Nationwide Inpatient Sample. The study population included 14, 970, 064 deliveries for national estimates from January 2012 to September 2015. The exposure was 48, 240 pregnancies after ART. The main outcome measure encompassed three abnormal placentation pathologies (placenta previa [PP], placenta accreta spectrum [PAS], and vasa previa [VP]). Propensity score matching was performed to assess the exposure-outcome association.

Results: Pregnancy after ART was more likely to have a diagnosis of PAS (2.8 vs 1.0 per 1000 deliveries; adjusted odds ratio [aOR], 2.06 [95% confidence interval (CI), 1.44-2.93]), PP (24.5 vs 8.6 per 1000; aOR, 2.98 [95% CI, 2.64-3.35]), and VP (2.3 vs <0.3 per 1000; aOR, 11.3 [95% CI, 5.86-21.8]) compared with pregnancy without ART. Similarly, pregnancy after ART was associated with an increased likelihood of having multiple types of abnormal placentation, including VP with PP (aOR, 15.4 [95% CI, 6.15-38.4]) and PAS with PP (aOR, 2.80 [95% CI, 1.32-5.92]) compared with non-ART pregnancy.

Conclusions: This national-level analysis suggests that pregnancy after ART is associated with a significantly increased risk of abnormal placentation, including PAS, PP, and VP.

Keywords: assisted reproductive technology; placenta accreta spectrum; placenta previa; pregnancy; vasa previa.

PubMed Disclaimer

References

REFERENCES

    1. Zegers-Hochschild F, Adamson GD, Dyer S, et al. The international glossary on infertility and fertility care, 2017. Hum Reprod. 2017;32(9):1786-1801.
    1. Fauser BC. Towards the global coverage of a unified registry of IVF outcomes. Reprod Biomed Online. 2019;38(2):133-137.
    1. SART. National Summary Report 2020. Available from: https://www.sartcorsonline.com/rptCSR_PublicMultYear.aspx?reportingYear=...
    1. Ghidini A, Gandhi M, McCoy J, Kuller JA. Society for Maternal-Fetal Medicine Consult Series #60: management of pregnancies resulting from in vitro fertilization. Am J Obstet Gynecol. 2022;226(3):B2-b12.
    1. Sunderam S, Kissin DM, Zhang Y, et al. Assisted reproductive technology surveillance - United States, 2018. MMWR Surveill Summ. 2022;71(4):1-19.

LinkOut - more resources